UK markets closed

Ayala Pharmaceuticals, Inc. (ADXS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5550+0.0050 (+0.91%)
At close: 11:14AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
13
13
692
3,506
3,708
Cost of revenue
13
13
602
3,506
3,708
Gross profit
0
0
90
0
0
Operating expenses
Research development
24,081
24,081
27,851
29,941
22,406
Selling general and administrative
12,185
12,185
9,742
9,277
7,371
Total operating expenses
36,266
36,266
37,593
39,218
29,777
Operating income or loss
-36,266
-36,266
-37,503
-39,218
-29,777
Interest expense
15,746
15,746
0
260
-
Income before tax
-51,984
-51,984
-37,429
-39,478
-29,721
Income tax expense
-3,912
-3,912
584
776
425
Income from continuing operations
-48,072
-48,072
-38,013
-40,254
-30,146
Net income
-48,072
-48,072
-38,013
-40,254
-30,146
Net income available to common shareholders
-48,072
-48,072
-38,013
-40,254
-30,146
Basic EPS
-2.51
-7.99
-13.13
-2.80
-3.06
Diluted EPS
-2.51
-7.99
-13.13
-2.80
-3.06
Basic average shares
15,325
6,019
2,895
14,399
9,861
Diluted average shares
15,325
6,019
2,895
14,399
9,861